Allurion presents data on increasing muscle mass and decreasing fat mass in patients treated with the allurion program

Natick, mass.--(business wire)---- $alur--allurion technologies, inc. (“allurion” or the “company”) (nyse: alur), a pioneer in metabolically healthy weight loss, today announced the presentation of a study at the societe francaise et francophone de chiurgie de l'obesite et des maladies metaboliques (soffco.mm) meeting in saint-etienne, france, may 22-23, 2025. the study, entitled “the swallowable gastric balloon program with ai powered health coach leads to metabolically healthy weight loss in french pat.
ALUR Ratings Summary
ALUR Quant Ranking